Is there a relationship between COVID-19 and sarcoidosis? A case report

<p>Mediastinal lymphadenopathy is rare in Coronavirus Disease-2019 (COVID-19) patients with mild clinical course. The frequency of lymphadenopathy increases in COVID-19 patients who develop Acute Respiratory Distress Syndrome (ARDS). In a 38-year-old male patient, mediastinal lymphadenopathy a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasar Kucukardali (Author), Arzu Gunturk (Author), Mehmet Akif Ozturk (Author), Şenay Acikel (Author), Hatice Zeynep Ceylan (Author), Pınar Fırat (Author), Banu Salepci (Author)
Format: Book
Published: Archives of Pulmonology and Respiratory Care - Peertechz Publications, 2022-11-19.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_aprc_000080
042 |a dc 
100 1 0 |a Yasar Kucukardali  |e author 
700 1 0 |a  Arzu Gunturk  |e author 
700 1 0 |a  Mehmet Akif Ozturk  |e author 
700 1 0 |a  Şenay Acikel  |e author 
700 1 0 |a  Hatice Zeynep Ceylan  |e author 
700 1 0 |a  Pınar Fırat  |e author 
700 1 0 |a Banu Salepci  |e author 
245 0 0 |a Is there a relationship between COVID-19 and sarcoidosis? A case report 
260 |b Archives of Pulmonology and Respiratory Care - Peertechz Publications,   |c 2022-11-19. 
520 |a <p>Mediastinal lymphadenopathy is rare in Coronavirus Disease-2019 (COVID-19) patients with mild clinical course. The frequency of lymphadenopathy increases in COVID-19 patients who develop Acute Respiratory Distress Syndrome (ARDS). In a 38-year-old male patient, mediastinal lymphadenopathy and asymptomatic pulmonary embolism were detected during the third week of COVID-19 infection at home. Sarcoidosis was diagnosed with a finding of non-caseating granulomas. Even if it is asymptomatic, pulmonary embolism should be considered, especially in COVID-19 patients with high C - Reactive Protein (CRP) and D-dimer levels. If mediastinal lymphadenopathy is detected in mild COVID-19 cases, systemic diseases should be investigated. In severe COVID-19 cases, if lymphadenopathy continues despite a COVID-19 recovery, further investigation is required.</p> 
540 |a Copyright © Yasar Kucukardali et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/aprc.000080  |z Connect to this object online.